Allspring Global Investments Holdings LLC lessened its holdings in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 0.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,385,807 shares of the specialty chemicals company's stock after selling 19,963 shares during the period. Allspring Global Investments Holdings LLC owned 9.57% of Innospec worth $256,808,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in IOSP. Sanctuary Advisors LLC acquired a new stake in shares of Innospec during the 2nd quarter worth about $233,000. Inspire Investing LLC increased its position in Innospec by 28.9% during the third quarter. Inspire Investing LLC now owns 3,651 shares of the specialty chemicals company's stock worth $413,000 after buying an additional 819 shares during the period. ZWJ Investment Counsel Inc. increased its position in Innospec by 3.6% during the third quarter. ZWJ Investment Counsel Inc. now owns 43,147 shares of the specialty chemicals company's stock worth $4,879,000 after buying an additional 1,504 shares during the period. nVerses Capital LLC increased its position in Innospec by 200.0% during the third quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company's stock worth $102,000 after buying an additional 600 shares during the period. Finally, AlphaMark Advisors LLC increased its position in Innospec by 19.2% during the third quarter. AlphaMark Advisors LLC now owns 3,036 shares of the specialty chemicals company's stock worth $343,000 after buying an additional 488 shares during the period. Institutional investors and hedge funds own 96.64% of the company's stock.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered Innospec from a "strong-buy" rating to a "buy" rating in a research report on Saturday, January 11th.
Get Our Latest Stock Report on Innospec
Innospec Stock Down 3.2 %
IOSP traded down $3.61 during trading on Friday, hitting $108.19. 154,173 shares of the stock were exchanged, compared to its average volume of 114,648. The firm has a market capitalization of $2.70 billion, a P/E ratio of 18.88 and a beta of 1.09. Innospec Inc. has a 1-year low of $103.65 and a 1-year high of $133.71. The stock has a fifty day moving average price of $111.96 and a two-hundred day moving average price of $113.11.
About Innospec
(
Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Recommended Stories
Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
